Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss (Q22241931)

Thomas D

Giles

2

1 reference

8 February 2023

George A Bray

George A

Bray

3

1 reference

8 February 2023

Yuling Hong

Yuling

Hong

4

1 reference

8 February 2023

Judith S Stern

Judith S

Stern

5

1 reference

8 February 2023

F Xavier Pi-Sunyer

F Xavier

Pi-Sunyer

6

1 reference

8 February 2023

Robert H Eckel

Robert H

Eckel

Arteriosclerosis, Thrombosis, and Vascular Biology

7

1 reference

8 February 2023

language of work or name

English

0 references

publication date

9 February 2006

0 references

published in

0 references

volume

26

0 references

page(s)

968-976

0 references

issue

5

0 references

cites work

Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913"

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body mass index and the risk of stroke in men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

CORONARY DISEASE AMONG UNITED STATES SOLDIERS KILLED IN ACTION IN KOREA

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Weight and blood pressure. Findings in hypertension screening of 1 million Americans.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

A prospective study of risk factors for pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

A prospective study of body mass index, weight change, and risk of stroke in women.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Years of life lost due to obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Fatty infiltration: another restrictive cardiomyopathic pattern

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Pseudopericardial effusion: echocardiographic and computed tomographic correlations

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The effect of acute hyperglycaemia on QTc duration in healthy man

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

High glucose induces ventricular instability and increases vasomotor tone in rats

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Myocardial fat infiltration

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiac failure and sudden death in the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study).

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Sensitivity and specificity of electrocardiographic criteria for left and right ventricular hypertrophy in morbid obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Correlation of intraabdominal fat accumulation and left ventricular performance in obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

A new method for indexing left ventricular mass for differences in body size.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Tackling the challenge of cardiovascular disease burden in developing countries

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Impact of obesity on long-term prognosis following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Differential clinical prognostic classifications in dilated and ischemic adbanced heart failure: The EPICAL study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body composition and prognosis in chronic systolic heart failure: the obesity paradox

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The electrocardiogram in morbid obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Effects of obesity on QT, RR, and QTc intervals

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Risk factors for heart failure in the elderly: a prospective community-based study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The electrocardiogram in obesity.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Gross fragmentation of cardiac myofibrils after therapeutic starvation for obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity exacerbates chemically induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Exercise in weight management of obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The relationship between obesity and mortality in patients with heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The associations of body size and body composition with left ventricular mass: impacts for indexation in adults

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Risk of morbidity and in-hospital mortality in obese patients undergoing coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body mass index and the prevalence of hypertension and dyslipidemia

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity and long-term clinical and economic outcomes in coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Relationship between waist circumference, body mass index, and medical care costs.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The human obesity gene map: the 2003 update

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Visceral fat and coronary pathology in male adolescents

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Myocardial infarction and coronary pathology in severely obese people examined at autopsy

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Heart failure in the general population of men--morbidity, risk factors and prognosis

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Components of the insulin resistance syndrome are associated with progression of atherosclerosis in non-grafted arteries 5 years after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The prognosis of heart failure in the general population: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiac arrhythmias associated with a liquid protein diet for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

A prospective study of obesity and risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The occurrence of sleep-disordered breathing among middle-aged adults

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Effects of the amount and intensity of exercise on plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity and the risk of heart failure

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Lipotoxic heart disease in obese rats: implications for human obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Natural history and risk factors of atherosclerosis in children and youth: the PDAY study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Sudden death associated with very low calorie weight reduction regimens

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Origin of atherosclerosis in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Body size and fat distribution as predictors of stroke among US men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Why is left ventricular hypertrophy so predictive of morbidity and mortality?

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Bogalusa Heart Study: a long-term community study of a rural biracial (black/white) population

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiovascular function in extreme obesity.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Overweight and stroke in the Whitehall study

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Use of drugs in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity accelerates the progression of coronary atherosclerosis in young men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Snoring and sleep apnea. A population study in Australian men.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Sibutramine. A review of its contribution to the management of obesity.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Intentional weight loss and mortality among overweight individuals with diabetes.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

The relationship between National Heart, Lung, and Blood Institute Weight Guidelines and concurrent medical costs in a manufacturing population.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older.

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

Dimorphic cardiac adaptation to obesity and arterial hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.ATV.0000216787.85457.F3

7 January 2021

10.1161/01.ATV.0000216787.85457.F3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

791036

791036

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference